Regarding the association between REV-7 expression and various clinicopathological characteristics, the authors reported that higher REV-7 immunohistochemical expression was associated with smaller tumor volume, earlier TNM stage, less invasion, and a lower possibility of distant metastasis in colorectal cancer patients. The gene discussed is MAD2L2; the disease is colorectal cancer.